Market Place
Sourcing Support
Rivus Weight Loss Drug Shows MASH Win, Muscle-Sparing Potential
25 Jun 2025 //
PR NEWSWIRE
Rivus Ph 2 HU6 Trial Shows Liver Fat Drop in MASH Patients
24 Jun 2025 //
PR NEWSWIRE
Rivus Pharmaceuticals Expands Leadership Team
10 Apr 2025 //
CONTRACTPHARMA
Rivus Publishes Ph2a HuMAIN Trial Of HU6 In JAMA Cardiology
12 Mar 2025 //
PR NEWSWIRE
Rivus posts data to back up muscle-sparing obesity drug claims
30 Sep 2024 //
FIERCE BIOTECH
Rivus To Present HU6 HuMAIN Trial Data At HFSA 2024
23 Sep 2024 //
PR NEWSWIRE
Rivus Pharma`s HuMAIN Trial Meets Weight Loss Endpoints In Obesity Heart Failure
14 Aug 2024 //
PR NEWSWIRE
Rivus Succeeds In Obesity-Related Heart Failure With Phase 2 Win
13 Aug 2024 //
FIERCE BIOTECH
Rivus` HuMAIN Trial Meets Endpoints In Obesity-Related Heart Failure
13 Aug 2024 //
PR NEWSWIRE
Rivus Pharma Publishes Phase 2a HuMAIN Trial Design In Heart Failure Journal
26 Jun 2024 //
PR NEWSWIRE
Rivus Pharma Announces Completion of Enrollment in Phase 2a HuMAIN Trial of HU6
05 Jan 2024 //
PR NEWSWIRE
Rivus Announces Expansion of HU6 Clinical Program and Leadership Appointments
15 Nov 2023 //
PR NEWSWIRE
Phase 2a of HU6, Rivus` Controlled Metabolic Accelerator, Demonstrates Benefit
05 Oct 2023 //
PR NEWSWIRE
Rivus to Present Results from a Phase 2a Trial Evaluating HU6
04 Nov 2022 //
PRNEWSWIRE
Rivus raises $132m to advance clinical development of obesity treatment
23 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Rivus raises $132M series B as metabolic pipeline heats up
22 Sep 2022 //
FIERCEBIOTECH
Rivus Pharmaceuticals Closes $132 Million Series B Financing to Advance HU6
22 Sep 2022 //
PRNEWSWIRE
Rivus throws down liver fat data on quest to climb NASH mountain
10 Feb 2022 //
FIERCEBIOTECH
Rivus Pharma shows +ve results from phase 1 trial of HU6
02 Nov 2021 //
PHARMABIZ
Rivus Pharmaceuticals Announces Positive Results from Phase 1 Trial
01 Nov 2021 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.